Grifols | GRFS - 流动资产

金融业

EUR

EUR 23.15B

现金及等价物

EUR 979.78M

EUR 1.51B

EUR 5.96B

EUR 2.37B

EUR 9.23B

股息收益率

EUR 1.88

EUR 320.55M

EUR 482.05M

EUR 23.83K

EPS每股收益

EUR 0.29

股本和储备

EUR 6.21B

EUR 766.49M

债务利息支出

EUR 156.07M

EUR 9.95B

EUR 2.12B

EUR 114.37M

EUR 1.99B

EUR 320.55M

普通股股本

EUR 680.58M

11.2

EUR 257.85M

EUR 2.34B

销售和管理费用

EUR 320.45M

EUR 3.56B

贸易债权人

EUR 987.75M

应收帐款人

EUR 1B

	流动资产	更改		日
Alaunos Therapeutics	USD 2.68M		1.05M	2025-09
Arca Biopharma	USD 343.86M		11.31M	2025-12
aTyr Pharma	USD 245.8M		152.79M	2025-12
Bio Path	USD 663K		17K	2025-09
Brainstorm Cell Therapeutics	USD 307K		201K	2025-12
Capricor Therapeutics	USD 322.94M		221.99M	2025-12
Cara Therapeutics	USD 38.44M		4.69M	2025-09
Esperion Therapeutics	USD 462.57M		102.11M	2025-12
GlaxoSmithKline	GBP 17.51B		332M	2025-12
Grifols	EUR 5.96B		316.31M	2025-12
Immunic	USD 39.27M		20.57M	2025-09
Infinity Pharmaceuticals	USD 19.91M		8.46M	2023-06
Minerva Neurosciences	USD 83.1M		70.08M	2025-12
Nektar Therapeutics	USD 266.27M		15.09M	2025-12
Sangamo BioSciences	USD 49.89M		12.3M	2025-06
TherapeuticsMD	USD 11.82M		303K	2024-06